Overview
BDRX market data
Price History
BDRX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.00 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.40 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -1,858.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.02 – $59.40 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $7B · P/B 0.09 · P/S 13,521.54.
Company News
Biodexa Pharmaceuticals shares are trading lower. The company announce that it has held its first round table meeting in Paris, France as part of expanding its support for Familial Adenomatous Polyposis patients and prescribers.Benzinga · Jul 29, 2026, 2:22 PM
Biodexa Pharmaceuticals Holds First Round Table Meeting In France To Expand Support For Familial Adenomatous Polyposis Patients, PrescribersBenzinga · Jul 29, 2026, 12:33 PM
12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga · Jul 23, 2026, 9:10 PM
Biodexa Prices $3.5M Offering And Concurrent Private Placement Of 282,952 Shares At $2.85/ADS.Benzinga · Jun 30, 2026, 12:05 PM